Business

Rep. Barragán with President Biden & Vice President Harris for Lower Prescription Drug Price Announcement

 

LARGO, MD — Rep. Nanette Barragán (CA-44) joined President Joe Biden and Vice President Kamala Harris Aug 15 for their announcement of the first negotiated drug prices under Medicare through the Inflation Reduction Act, passed by Democrats and signed by President Biden two years ago.

In a historic first, the Inflation Reduction Act allows Medicare to negotiate prescription drug prices directly with drug companies for the first time, similar to the U.S. Department of Veterans Affairs and other federal agencies that already negotiate drug prices. The new prices for the first 10 drugs selected for negotiation will take effect in Medicare beginning in 2026.

“Two years ago, President Biden, Vice President Harris, and Democrats in Congress delivered on our promise to start lowering prescription drug costs for Americans,” said Rep. Barragán. “The Inflation Reduction Act ,for the first time, gave Medicare the power to reduce the skyrocketing price of prescription drugs that disproportionately impact low-income communities and communities of color. The negotiated drug prices announced today will help millions of Americans afford their medication for diabetes, cancer, heart failure and much more. In the first year alone, this will mean $1.5 billion in out-of-pocket savings for older Americans and people with disabilities who depend on these life saving medications, including over 800,000 Californians. I was proud to join President Biden and Vice President Harris in Maryland today to celebrate this historic accomplishment, made possible by Democrats in Congress. We will continue to fight to lower costs for American families everywhere.”

The new prices of the ten drugs announced today are:

Drug Commonly Treated Conditions List Price Negotiated Price
Eliquis

 

Prevention and treatment of blood clots $521 $231
Jardiance Diabetes, heart failure, chronic kidney disease $573 $197
Xarelto Prevention and treatment of blood clots, reduction of risk for patients with coronary or peripheral artery disease $517 $197
Januvia Diabetes $527 $113
Farxiga Diabetes, heart failure, chronic kidney disease $556 $178.50
Entresto Heart failure $628 $295
Enbrel Rheumatoid arthritis, psoriasis, psoriatic arthritis $7,106 $2,355
Imbruvica Blood cancers $14,934 $9,319
Stelara Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis $13,836 $4,695
Fiasp; NovoLog Diabetes $495 $119

 

 

Reporters Desk

Recent Posts

Long Beach Announcements: Community Meeting on Marine Debris and Trash Capture and Homelless Count Volunteers Needed

City of Long Beach to Host Community Meeting on Marine Debris and Trash Capture System…

15 hours ago

Labor Caucus Urges Starbucks to Reach First Contract With Workers

The letter was signed by 88 House Democrats.

17 hours ago

Supervisors to Explore Ban on Predatory Solicitation Around County Buildings

The report alleges that the Downtown LA Law Group paid recruiters to aggressively target people…

17 hours ago

McOsker Briefs: Food Resources and Rent Increase Program Transparency

Through this motion, the city council aims to ensure that the city can maintain a…

18 hours ago

Public Health Alert: Infant Botulism Outbreak Linked to ByHeart Powdered Infant Formula

The Los Angeles County Department of Public Health is alerting parents and caregivers about an…

18 hours ago

NewFilmmakers Los Angeles’ Student Mentorship Program Offering Upcoming Sessions at NBCUniversal, Approximately 25 spots are available.

  Below is a general overview of the program: NFMLA’s CineSessions High School Student Mentorship…

19 hours ago